Harmonised classification and labelling previous targeted consultations

These targeted consultations for CLH proposals are closed. The consultations are launched in case further information is needed on a particular hazard class, or if comments are sought on e.g. a specific additional document.

The comments received during the consultation are available on the Registry of CLH intentions until outcome.

 

There are currently no ongoing consultations.
 
(RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy}ethyl methyl carbonate; tolpyralate - 1101132-67-5 United Kingdom Carc. 2, H351
STOT RE 2, H373
Aquatic Acute 1, H400, M = 10
Aquatic Chronic 1, H410, M=100
Details
1-isopropyl-4-methylbenzene; p-cymene 202-796-7 99-87-6 Netherlands Flam. Liq. 3, H226,
Acute Tox. 3, H331,
Asp. Tox. 1, H304,
Aquatic Acute 1, H400,
Aquatic Acute 1, M-factor=1,
Aquatic Chronic 3, H412
Details
2-butoxyethanol; ethylene glycol monobutyl ether 203-905-0 111-76-2 603-014-00-0 Article 77(3) request Acute Tox. 4*; H332
Acute Tox. 4*; H312
Acute Tox. 4*; H302
Skin Irrit. 2; H315
Eye Irrit. 2; H319
Acute Tox. 3; H331
Acute Tox. 4; H302
Skin Irrit. 2; H315
Eye Irrit. 2; H319

inhalation: ATE = 3 mg/L
oral: ATE = 1200 mg/kg bw
Details
3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctan-1-ol 211-477-1 647-42-7 Germany STOT RE2, H373 (skeletal system)

Aquatic Chronic 2, H411
Details
3-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate 259-627-5 55406-53-6 616-212-00-7 Denmark Acute Tox. 3, H331
Acute Tox. 4, H302,
STOT RE 1, H372 (larynx)
Eye Dam. 1, H318,
Skin Sens. 1, H317,
Aquatic Acute 1, H400, M = 10,
Aquatic Chronic 1, H410, M = 1
Acute Tox. 2, H330,
Acute Tox. 4, H302,
STOT RE 1, H372 (larynx)
Eye Dam. 1, H318,
Skin Sens. 1, H317,
Aquatic Acute 1, H400, M = 10,
Aquatic Chronic 1, H410, M = 10
Details
butanone oxime; ethyl methyl ketoxime; ethyl methyl ketone oxime 202-496-6 96-29-7 Germany Acute Tox. 4*, H312,
Eye Dam. 1, H318,
Skin Sens. 1, H317,
Carc. 2, H351
Acute Tox. 3, H301,
Acute Tox. 4, H312,
Eye Dam. 1, H318,
Skin Sens. 1B, H317,
Carc. 1B, H350,
STOT SE 3, H336
dermal: ATE = 1848 mg/kg
oral: ATE = 100 mg/kg
Details
Chrysanthemum cinerariaefolium, extract from open and mature flowers of Tanacetum cinerariifolium obtained with hydrocarbon solvents and Chrysanthemum cinerariaefolium, extract from open and mature flowers of Tanacetum cinerariifolium obtained with supercritical carbon dioxide 289-699-3 89997-63-7 Spain Acute Tox. 4, H302,
Acute Tox. 4, H332,
Skin Sens. 1B, H317,
Aquatic Acute 1, H400, M-factor=100,
Aquatic Chronic 1, H410, M-factor=10

ATE oral = 700 mg/kg bw
ATE inhalation = 2.5 mg/L (dusts and mists)
Details
clomazone (ISO); 2-(2-chlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one 617-258-0 81777-89-1 Denmark Acute Tox. 4, H302,
Acute Tox. 4, H332,
Repr. 1B, H360D,
Aquatic Acute 1, H400,
Aquatic Acute 1, M-factor=1,
Aquatic Chronic 1, H410,
Aquatic Chronic 1, M-factor=1
Details
Copper compounds - - M-factors for long-term aquatic hazard Details
cypermethrin (ISO); α-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; cypermethrin cis/trans +/- 40/60 257-842-9 52315-07-8 607-421-00-4 Belgium Acute Tox. 4*, H332
Acute Tox. 4*, H302
STOT SE 3, H335
Aquatic Acute 1, H400
Aquatic Chronic 1, H410
Acute Tox. 4*, H332
Acute Tox. 4*, H302
STOT SE 3, H335
Aquatic Acute 1, H400 (M=100000)
Aquatic Chronic 1, H410 (M=1000)
Details
daminozide (ISO); 4-(2,2-dimethylhydrazino)-4-oxobutanoic acid; N-dimethylaminosuccinamic acid 216-485-9 1596-84-5 Czech Republic Carc. 1B, H350 Details
diflufenican (ISO); N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide 617-446-2 83164-33-4 616-032-00-9 United Kingdom Aquatic Chronic 3, H412 Aquatic Acute 1, H400
Aquatic Chronic 1, H410
Details
Flumioxazin (ISO),N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide - 103361-09-7 613-166-00-X Czech Republic Repr. 1B, H360D,
Aquatic Acute 1, H400,
Aquatic Acute 1, M-factor=1000,
Aquatic Chronic 1, H410,
Aquatic Chronic 1, M-factor=1000
Repr. 2, H361d,
Aquatic Acute 1, H400,
Aquatic Acute 1, M-factor=1000,
Aquatic Chronic 1, H410,
Aquatic Chronic 1, M-factor=1000
Details
Glyphosate 213-997-4 1071-83-6 607-315-00-8 Sweden Eye Dam. 1, H318,
Aquatic Chronic 2, H411
Eye Dam. 1, H318,
Aquatic Chronic 2, H411
Details
hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate; hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate 443-860-6 302776-68-7 607-693-00-4 Germany Aquatic Chronic 4, H413 Aquatic Chronic 1, H410, M-factor = 1000 Details
Hexyl salicylate 228-408-6 6259-76-3 France Skin Sens. 1, H317,
Repr. 2, H361d
Details
lead 231-100-4 7439-92-1 082-013-00-1
082-014-00-7
Article 77(3) request Repr. 1A, H360FD
Lact., H362
Repr. 1A, H360FD
Lact., H362
Aquatic Acute 1, H400; M=1
Aquatic Chronic 1, H410; M=10
Details
lithium carbonate [1] lithium chloride [2] lithium hydroxide [3]
209-062-5
231-212-3
215-183-4
554-13-2
7447-41-8
1310-65-2
TBD Article 77(3) request Repr. 1A, H360FD
Lact., H362
Details
lithium carbonate [1] lithium chloride [2] lithium hydroxide [3]
209-062-5
231-212-3
215-183-4
554-13-2
7447-41-8
1310-65-2
France Repr. 1A, H360FD Details
MCPA-thioethyl (ISO); S-ethyl (4-chloro-2-methylphenoxy)ethanethioate; S-ethyl 4-chloro-o-tolyloxythioacetate 246-831-4 25319-90-8 246-831-4 Poland Acute Tox. 4, H302,
Aquatic Acute 1, M-factor=10,
Aquatic Chronic 1, M-factor=10
Details
Melaleuca alternifolia, ext. Melaleuca alternifolia, essential oil; tea tree oil 285-377-1
85085-48-9
68647-73-4
Poland Flam. Liq. 3, H226,
Acute Tox. 4, H302,
oral: ATE = 1049 mg/kg bw
Acute Tox. 4, H332,
inhalation: ATE = 3.64 mg/L (mist)
Skin Irrit. 2, H315,
Skin Sens. 1B, H317,
Repr. 2, H361f,
Asp. Tox. 1, H304,
Aquatic Acute 1, H400,
M-factor=1,
Aquatic Chronic 3, H412
Details
methyl methacrylate methyl 2-methylprop-2-enoate methyl 2-methylpropenoate 201-297-1 80-62-6 607-035-00-6 France Flam. Liq. 2, H225
Skin Irrit. 2, H315
Skin Sens. 1, H317
STOT SE 3, H335
Flam. Liq. 2, H225
Skin Irrit. 2, H315
Resp. Sens. 1, H334
Skin Sens. 1, H317
STOT SE 3, H335
Details
methyl methacrylate; methyl 2-methylprop-2-enoate; methyl 2-methylpropenoate 201-297-1 80-62-6 607-035-00-6 Article 77(3) request Flam. Liq. 2, H225
Skin Irrit. 2, H315
Skin Sens. 1, H317
STOT SE 3, H335
Flam. Liq. 2, H225
Resp. Sens. 1, H 334
Skin Irrit. 2, H315
Skin Sens. 1, H317
STOT SE 3, H335
Details
metribuzin (ISO); 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one 244-209-7 21087-64-9 606-034-00-8 Estonia Acute Tox. 4*, H302,
Aquatic Acute 1, H400, Aquatic Acute 1, M-factor=10,
Aquatic Chronic 1, H410, Aquatic Chronic 1
Acute Tox. 4, H302,
STOT RE 2, H373,
Aquatic Acute 1, H400, Aquatic Acute 1, M-factor=10,
Aquatic Chronic 1, H410, Aquatic Chronic 1, M-factor=100
ATE 322 mg/kg bw
Details
metyltetraprole (ISO); 1-[2-({[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}methyl)-3-methylphenyl]-4-methyl-1,4-dihydro-5H-tetrazol-5-one - 1472649-01-6 France Carc. 2, H351,
Aquatic Acute 1, H400, M = 10,
Aquatic Chronic 1, H410, M = 1
Details
N(1,3-dimethylbutyl)-N'-phenyl-p-phenylenediamine 212-344-0 793-24-8 Austria Acute Tox. 4, H302,
Skin Sens. 1A, H317,
Repr. 1B, H360FD,
Aquatic Acute 1, H400,
M-factor=10 000,
Aquatic Chronic 1, H410,
M-factor=10

Oral: ATE = 890 mg/kg bw
Details
N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide; isoflucypram - 1255734-28-1 United Kingdom Acute Tox. 4, H332,
Skin Sens. 1B, H317,
Aquatic Acute 1, H400,
Aquatic Acute 1, M-factor=10,
Aquatic Chronic 1, H410,
Aquatic Chronic 1, M-factor=1
ATE = 2.2 mg/L
Details
N-(hydroxymethyl)acrylamide; methylolacrylamide; [NMA] 213-103-2 924-42-5 France Muta. 1B, H340,
Carc. 1B, H350,
STOT RE 1, H372
Details
N-carboxymethyliminobis(ethylenenitrilo)tetra(acetic acid); Pentapotassium 2,2',2'',2''',2''''-(ethane-1,2-diylnitrilo)pentaacetate; Pentasodium (carboxylatomethyl)iminobis(ethylenenitrilo)tetraacetate
200-652-8
404-290-3
205-391-3
67-43-6
7216-95-7
140-01-2
Commission Details
pendimethalin (ISO); N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidene 254-938-2 40487-42-1 609-042-00-X Netherlands Skin Sens. 1; H317
Aquatic Acute 1; H400
Aquatic Chronic 1; H410
Repr. 2; H361d
Skin Sens. 1B; H317
Aquatic Acute 1; H400 (M=100)
Aquatic Chronic 1; H410 (M=10)
Details
prothioconazole (ISO); 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione - 178928-70-6 United Kingdom Aquatic Acute 1, H400,
Aquatic Chronic 1, H410
Details
pyrithione zinc; (T-4)-bis[1-(hydroxy-.kappa.O)pyridine-2(1H)-thionato-.kappa.S]zinc 236-671-3 13463-41-7 Sweden Acute Tox. 3, H301,
Acute Tox. 2, H330,
Eye Dam. 1, H318,
Repr. 1B, H360D,
STOT RE 1, H372,
Aquatic Acute 1, H400,
M-factor=1000,
Aquatic Chronic 1, H410,
M-factor=10
Details
pyrithione zinc; (T-4)-bis[1-(hydroxy-.kappa.O)pyridine-2(1H)-thionato-.kappa.S]zinc 236-671-3 13463-41-7 Sweden Acute Tox. 3, H301
Acute Tox. 2, H330
Eye Dam. 1, H318
Repr. 1B, H360D
STOT RE 1, H372
Aquatic Acute 1, H400
Aquatic Acute 1, M-factor=1000
Aquatic Chronic 1, H410
Aquatic Chronic 1, M-factor=10
Details
S-metolachlor (ISO); 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide; (RaSa)-2-chloro-N-(6-ethyl-o-tolyl)-N-[(1S)-2-methoxy-1-methylethyl]acetamide [contains 80-100 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide and 0-20 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2R)-1-methoxypropan-2-yl]acetamide] - 87392-12-9 607-432-00-4 Germany Skin Sens. 1; H317
Aquatic Acute 1; H400
Aquatic Chronic 1; H410
Carc. 2; H351
Repr. 2; H361d
STOT RE 2; H373 (skin)
Skin Sens. 1; H317
Aquatic Acute 1 H400 (M=10)
Aquatic Chronic 1 H410 (M=10)
Details
Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-, hydrolysis products with silica 272-697-1 68909-20-6 France STOT RE 2, H373;
Acute Tox. 2, H330
ATE = 0.45 mg/L (dusts and mists)
Details
Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-, hydrolysis products with silica 272-697-1 68909-20-6 014-052-00-7 Article 77(3) request STOT RE 2, H373 (lungs, inhalation) Acute Tox. 2, H330
STOT RE 2, H373 (lungs, inhalation)
inhalation: ATE = 0,45 mg/L
Details
Silver 231-131-3 7440-22-4 Sweden Skin Sens. 1, H317,
Muta. 2, H341,
Repr. 1B, H360FD,
Aquatic Acute 1, H400, M-factor=10 (for silver),
Aquatic Acute 1, H400, M-factor=1000 (for nano silver),
Aquatic Chronic 1, H410, M-factor=10 (for silver),
Aquatic Chronic 1, H410, M-factor=100 (for nano silver)
Details
Silver 231-131-3 7440-22-4 Sweden Skin Sens. 1, H317,
Muta. 2, H341,
Repr. 1B, H360FD,
Aquatic Acute 1, H400, M-factor=10 (for silver),
Aquatic Acute 1, H400, M-factor=1000 (for nano silver),
Aquatic Chronic 1, H410, M-factor=10 (for silver),
Aquatic Chronic 1, H410, M-factor=100 (for nano silver)
Details
transfluthrin (ISO); 2,3,5,6-tetrafluorobenzyl (1R,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 405-060-5 118712-89-3 607-223-00-8 Netherlands Skin Irrit. 2, H315
Aquatic Acute 1, H400
Aquatic Chronic 1, H410
Acute Tox. 4, H302
Carc. 2, H351
STOT SE 1, H370
STOT RE 2, H373
Aquatic Acute 1, H400, M-factor=1000
Aquatic Chronic 1, H410, M-factor=1000
oral: ATE = 583 mg/kg bw
Details